Clinical Practice Guidelines (CPG) on EBMonFHIR
0.8.0-snapshot - ci-build
Clinical Practice Guidelines (CPG) on EBMonFHIR - Local Development build (v0.8.0-snapshot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
{
"resourceType" : "Composition",
"id" : "COVID19IntensiveCareTreatmentGuideline",
"meta" : {
"profile" : [
🔗 "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/guideline"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Composition</b><a name=\"COVID19IntensiveCareTreatmentGuideline\"> </a><a name=\"hcCOVID19IntensiveCareTreatmentGuideline\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceComposition "COVID19IntensiveCareTreatmentGuideline" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-guideline.html\">Clinical Practice Guideline</a></p></div><p><b>identifier</b>: Resource identifier/113-001</p><p><b>version</b>: 7.0</p><p><b>status</b>: final</p><p><b>type</b>: Guidelines <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-ceosys-code-system.html\">CEOsys Code System</a>#clinical-practice-guideline; #e07eN1w1Rwswg4)</span></p><p><b>category</b>: Evidence- and consensus-based guideline <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-cs-guideline-stage-classification.html\">Guideline Stage Classification</a>#S3)</span></p><p><b>date</b>: 2022-03-01</p><p><b>author</b>: <a href=\"Organization-AWMFOrganization.html\">Organization/AWMFOrganization</a> "Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) e.V."</p><p><b>title</b>: Empfehlungen zur stationären Therapie von Patienten mit COVID-19 - Living Guideline</p><h3>RelatesTos</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>ResourceReference</b></td></tr><tr><td style=\"display: none\">*</td><td>citation</td><td><a href=\"Citation-COVID19IntensiveCareTreatmentGuidelineCitation.html\">Citation/COVID19IntensiveCareTreatmentGuidelineCitation</a> "COVID19_Intensive_Care_Treatment_Guideline"</td></tr></table></div>"
},
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "RI",
"display" : "Resource identifier"
}
]
},
"system" : "https://www.awmf.org/",
"value" : "113-001"
}
],
"version" : "7.0",
"status" : "final",
"type" : {
"coding" : [
{
"system" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/ceosys-code-system",
"code" : "clinical-practice-guideline"
},
{
"system" : "https://data.cochrane.org/concepts/",
"code" : "e07eN1w1Rwswg4",
"display" : "Guidelines"
}
]
},
"category" : [
{
"coding" : [
{
"system" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-guideline-stage-classification",
"code" : "S3",
"display" : "Evidence- and consensus-based guideline"
}
]
}
],
"date" : "2022-03-01",
"author" : [
{
🔗 "reference" : "Organization/AWMFOrganization"
}
],
"title" : "Empfehlungen zur stationären Therapie von Patienten mit COVID-19 - Living Guideline",
"relatesTo" : [
{
"type" : "citation",
"resourceReference" : {
🔗 "reference" : "Citation/COVID19IntensiveCareTreatmentGuidelineCitation"
}
}
],
"section" : [
{
"title" : "Stationäre Therapie von COVID-19 Patienten",
"code" : {
"coding" : [
{
"system" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/ceosys-code-system",
"code" : "guideline-recommendation",
"display" : "Clinical practice guideline recommendation"
}
]
},
"focus" : {
🔗 "reference" : "PlanDefinition/COVID19VentilatedPatientsDexamethasoneApplicationPlan"
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><strong>Systemische Steroide:</strong> Bei Patienten mit COVID-19- und Sauerstoff-Bedarf (Niedrigfluss-Sauerstoff-Insufflation, High-Flow Nasal Cannula, Nichtinvasive Beatmung/CPAP, invasive Beatmung) soll eine Therapie mit systemischen Kortikosteroiden erfolgen. Die Therapie sollte mit 6 mg Dexamethason p.o. oder i.v. über zehn Tage erfolgen.</div>"
}
},
{
"title" : "Stationäre Therapie von COVID-19 Patienten",
"code" : {
"coding" : [
{
"system" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/ceosys-code-system",
"code" : "guideline-recommendation",
"display" : "Clinical practice guideline recommendation"
}
]
},
"focus" : {
🔗 "reference" : "PlanDefinition/COVID19NonVentilatedPatientsDexamethasoneApplicationPlan"
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><strong>Systemische Steroide:</strong> Bei Patienten mit moderater Erkrankung (hospitalisiert ohne Notwendigkeit von Niedrigfluss-Sauerstoff-Insufflation) soll keine Therapie mit systemischen Kortikosteroiden erfolgen.</div>"
}
}
]
}